Celularity Achieves Impressive Revenue Growth Amid Financial Strains Celularity reported a 138% surge in revenue for 2024, reaching $54.2 million, driven by robust sales of its advanced biomaterial products. Despite this momentum, the company posted a $38.4 million loss for the year and highlighted ongoing liquidity concerns, raising questions about its ability to sustain growth in the near term.12